Press & Media

Medevio, the fastest-growing telemedicine platform in the Czech Republic, launches a new feature for migraine patients. Stable migraine patients undergoing biological treatment and attending regular check-ups at headache treatment centers can now join a pilot project for remote monitoring of migraine patients.

With remote monitoring, patients fill out their health status at designated intervals along with a digitized headache diary on their PC or smartphone. The patient's health history and diary records are then available both to the patient directly within the app and are automatically sent to the attending physician at the headache treatment center.

The platform also includes an interactive chat feature that allows patients to communicate with their doctor, enabling the detection of any deterioration in the patient's condition much earlier than during regular quarterly check-ups.

Thanks to automatic scoring evaluations and the simple transfer of results to outpatient and hospital programs, Medevio saves time not only for patients but also for doctors who previously had to manually evaluate paper diaries during regular visits.

In addition to remote monitoring, Medevio also launches an interface for the electronic "eRequest" – a validated recommendation for biological treatment, which the outpatient neurologist generates and sends directly through Medevio to the nearest headache treatment center. All of this is automated, eliminating the need for patient handling and scheduling.

Migraine patients can independently join the project by downloading the diary app at www.medevio.eu/migraine. In the app, they can verify whether their attending physician is participating in the project.

Medevio is the fastest-growing Czech telemedicine platform digitalizing healthcare in the Czech Republic. Medevio is used by over 600 doctors and 350,000 patients and is available through web, iPhone, and Android apps. In 2024, the platform celebrated its 1,000,000th processed patient request.

More at www.medevio.eu

Medevio, the fastest-growing telemedicine platform in the Czech Republic, launches a new initiative for patients with psoriasis. Stable psoriasis patients undergoing biological treatment who attend regular check-ups at one of the treatment centers can now participate in a pilot project for remote monitoring of psoriasis patients.

Through remote monitoring, patients fill out their disease status remotely at designated intervals, along with digitized questionnaires (DLQI, PEST, and PHQ-2) on their PC or smartphone. The medical history and score results are then available to the patient directly in the app and are automatically sent to the treating physician at the treatment center.

The platform also includes an interactive chat feature for patients to communicate with their doctor, allowing potential deterioration of the condition to be detected much earlier than during regular quarterly check-ups.

Thanks to the automatic evaluation of scores and easy transfer of results to outpatient and hospital programs, Medevio saves time not only for patients but also for doctors who previously had to manually fill out and calculate the questionnaires with patients during regular check-ups.

Psoriasis patients can join the project independently by downloading the diary app at www.medevio.eu/psoriasis. They can also check within the app whether their treating physician is involved in the project.

Medevio is the fastest-growing telemedicine platform in the Czech Republic, digitalizing healthcare in the country. It is used by more than 600 doctors and 350,000 patients and can be accessed via web, iPhone, and Android applications. In 2024, the platform celebrated 1,000,000 processed patient requests.

More information at www.medevio.eu.

Medevio, the fastest-growing telemedicine platform in the Czech Republic, is launching a new service for patients with ankylosing spondylitis (Bechterew's disease). Stable patients undergoing biological treatment who attend regular check-ups at specialized centers can now join a pilot project for remote monitoring of ankylosing spondylitis patients.

With remote monitoring, patients fill out their disease status at designated intervals, alongside digitalized questionnaires such as BASDAI, HAQ, BAS-G, and VAS, using their PC or smartphone. The disease history and score results are then available to the patient directly in the app and are automatically sent to the treating physician at the treatment center.

The platform also features an interactive chat function that allows patients to communicate with their doctor, enabling the detection of any worsening of the condition much earlier than during regular quarterly check-ups.

Thanks to the automatic evaluation of scores and the easy transfer of results to outpatient and hospital programs, Medevio saves time for both patients and doctors, who previously had to manually fill out and calculate the questionnaires during regular check-ups.

Patients with ankylosing spondylitis can join the project independently by downloading the disease diary app at www.medevio.eu/ankylosing-spondylitis. They can also verify within the app whether their treating physician is participating in the project.

Medevio is the fastest-growing telemedicine platform in the Czech Republic, revolutionizing healthcare through the digitalization of patient management. With over 600 doctors and 350,000 patients using the platform, it is available through web, iPhone, and Android apps. In 2024, the platform celebrated 1,000,000 processed patient requests.

For more information, visit www.medevio.eu.